Stockscreener 앱 받기
10.69
0.56%
-0.065
전일 마감가:
$10.75
열려 있는:
$10.76
하루 거래량:
101.99K
Relative Volume:
0.17
시가총액:
$624.75M
수익:
$1.12B
순이익/손실:
$55.30M
주가수익비율:
11.25
EPS:
0.95
순현금흐름:
$-30.30M
1주 성능:
-8.08%
1개월 성능:
+10.32%
6개월 성능:
-41.78%
1년 성능:
-32.13%
1일 변동 폭
$10.61
$10.82
1주일 범위
$10.61
$11.79
52주 변동 폭
$9.20
$21.48
Embecta Corp Stock (EMBC) Company Profile
명칭
Embecta Corp
전화
(862) 401-0000
주소
1209 ORANGE STREET, WILMINGTON
EMBC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
10.69 | 662.15M | 1.12B | 55.30M | -30.30M | 0.95 |
|
ISRG
Intuitive Surgical Inc
|
501.75 | 177.07B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
182.25 | 52.43B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
90.00 | 44.59B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
277.38 | 40.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
251.07 | 18.53B | 2.90B | 467.20M | 306.90M | 6.37 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | Wolfe Research | Peer Perform |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | 개시 | BTIG Research | Neutral |
| 2022-08-01 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-06-21 | 개시 | BofA Securities | Underperform |
모두보기
Embecta Corp 주식(EMBC)의 최신 뉴스
Fibonacci Levels Suggest Recovery for Embecta Corp.Scalable Portfolio Growth Suggestions Released - metal.it
Why Embecta Corp. stock attracts strong analyst attentionConservative Investment Strategy Review Forecast - beatles.ru
How does EMBC's Q2 2025 EPS forecast compare to past surprises? - AInvest
How did Embecta's revenue and expenses trend in Q1 2025? - AInvest
Will Embecta Corp. Reverse From Oversold ConditionsEntry Plan for Oversold Reversal Stocks Released - metal.it
Published on: 2025-07-28 16:33:37 - metal.it
Is Embecta Corp. a growth stock or a value stockInvest confidently with professional guidance - jammulinksnews.com
Why is Embecta Corp. stock attracting strong analyst attentionAchieve rapid portfolio growth with expert help - jammulinksnews.com
What are the latest earnings results for Embecta Corp.High-octane investment gains - jammulinksnews.com
Should I hold or sell Embecta Corp. stock in 2025Get timely advice on market trends - jammulinksnews.com
What analysts say about Embecta Corp. stockSuperior return velocity - PrintWeekIndia
Should I buy Embecta Corp. stock before earningsRecord-setting profit potential - jammulinksnews.com
Is Embecta Corp. a good long term investmentDynamic portfolio growth - PrintWeekIndia
What drives Embecta Corp. stock priceAccelerated financial growth - Autocar Professional
Embecta Corp to Host Conference Call Discussing Q3 2025 Financial Results and Operational Updates - Nasdaq
embecta to Report Fiscal Third Quarter 2025 Financial Results - GlobeNewswire
Embecta Earnings Call: Medical Supply Leader to Present Q3 Results and Strategic Updates - Stock Titan
Diabetes Care Market is evolving rapidly Through 2025 To 2032 | Medtronic, Abbott, Pumps It, Inc., Embecta Corp - openPR.com
Embecta Corp. Stock Analysis and ForecastGame-changing capital returns - Autocar Professional
(EMBC) Technical Data - news.stocktradersdaily.com
BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating - MSN
Mizuho Lowers PT on Embecta Corp. (EMBC) to $13 From $15, Keeps a Neutral Rating - MSN
Is Embecta Corp. a Contrarian Gem in a World Obsessed with Energy? - AInvest
Embecta Corp (EMBC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Embecta Corp 주식 (EMBC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Melcher David F | Director |
Feb 25 '25 |
Buy |
13.67 |
13,000 |
177,646 |
76,681 |
| Morris Milton Mayo | Director |
Feb 13 '25 |
Sale |
16.38 |
3,100 |
50,783 |
36,133 |
0.19%
0.75%
자본화:
|
볼륨(24시간):